Mediation of protein kinase C zeta in μ-opioid receptor activation for increase of glucose uptake into cultured myoblast C2C12 cells

Neuroscience Letters

Volumn 465, Issue 2, 2009, Pages 177-180

  Yang, Ting Ting ^a   Liu, I Min ^b   Wu, Hung Tsung ^c   Cheng, Juei Tang ^c,d  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b TAJEN UNIVERSITY   (Taiwan)

^c Institute of Biomedical Science   (Taiwan)

^d CHI MEI MEDICAL CENTER   (Taiwan)

Author keywords

Opioid receptors; C2C12 cells; Loperamide; Protein kinase C

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; DEOXYGLUCOSE; GLUCOSE; LOPERAMIDE; MU OPIATE RECEPTOR; NALOXONAZINE; PROTEIN KINASE C ZETA;

ANIMAL CELL; ARTICLE; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GLUCOSE TRANSPORT; MOUSE; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

ANIMALS; BLOTTING, WESTERN; CARBON RADIOISOTOPES; CELL LINE; DEOXYGLUCOSE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GLUCOSE; INDOLES; LOPERAMIDE; MALEIMIDES; MICE; MYOBLASTS, SKELETAL; NALOXONE; NARCOTIC ANTAGONISTS; PHOSPHORYLATION; PROTEIN KINASE C; RECEPTORS, OPIOID, MU;

EID: 70349306235     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.08.026     Document Type: Article

References (20)

1. Bandyopadhyay G., Standaert M.L., Sajan M.P., Karnitz L.M., Cong L., Quon M.J., and Farese R.V. Dependence of insulin-stimulated glucose transporter 4 translocation on 3-phosphoinositide-dependent protein kinase-1 and its target threonine-410 in the activation loop of protein kinase C-zeta. Mol. Endocrinol. 13 (1999) 1766-1772
2. Cheng J.T., Liu I.M., Chi T.C., Tzeng T.F., Lu F.H., and Chang C.J. Plasma glucose-lowering effect of tramadol in streptozotocin-induced diabetic rats. Diabetes 50 (2001) 2815-2821
3. Chevlen E. Opioids: a review. Curr. Pain Headache Rep. 7 (2003) 15-23
4. Farese R.V. Phospholipid signaling systems in insulin action. Am. J. Med. 85 (1988) 36-43
5. Guo H., Gu F., Li W., Zhang B., Niu R., Fu L., Zhang N., and Ma Y. Reduction of protein kinase C zeta inhibits migration and invasion of human glioblastoma cells. J. Neurochem. 109 (2009) 203-213
6. Ling G.S.F., Simantov R., Clark J.A., and Pasternak G.W. Naloxonazine actions in vivo. Eur. J. Pharmacol. 129 (1986) 33-38
7. 12 cells. Horm. Metab. Res. 36 (2004) 210-214
8. Liu L.Z., He A.B., Liu X.J., Li Y., Chang Y.S., and Fang F.D. Protein kinase C zeta and glucose uptake. Biochemistry (Mosc.) 71 (2006) 701-706
9. Mellor H., and Parker P.J. The extended protein kinase C superfamily. Biochem. J. 332 (1998) 281-292
10. Nielsen J.N., Frøsig C., Sajan M.P., Miura A., Standaert M.L., Graham D.A., Wojtaszewski J.F., Farese R.V., and Richter E.A. Increased atypical PKC activity in endurance-trained human skeletal muscle. Biochem. Biophys. Res. Commun. 312 (2003) 1147-1153
11. Parmentier J.H., Gandhi G.K., Wiggins M.T., Saeed A.E., Bourgoin S.G., and Malik K.U. Protein kinase C zeta regulates phospholipase D activity in rat-1 fibroblasts expressing the alpha1A adrenergic receptor. BMC Cell Biol. 5 (2004) 4
12. Perrini S., Henriksson J., Zierath J.R., and Widegren U. Exercise-induced protein kinase C isoform-specific activation in human skeletal muscle. Diabetes 53 (2004) 21-24
13. Smith E.M. Opioid peptides in immune cells. Adv. Exp. Med. Biol. 521 (2003) 51-68
14. Standaert M.L., Galloway L., Karnam P., Bandyopadhyay G., Moscat J., and Farese R.V. Protein kinase C-zeta as a downstream effector of phosphatidylinositol 3-kinase during insulin stimulation in rat adipocytes. Potential role in glucose transport. J. Biol. Chem. 272 (1997) 30075-30082
15. Tzeng T.F., Liu I.M., Lai T.Y., Tsai C.C., Chang W.C., and Cheng J.T. Loperamide increases glucose ultilization in streptozotocin-induced diabetic rats. Clin. Exp. Pharmacol. Physiol. 30 (2003) 734-738
16. Toullec D., Pianetti P., Coste H., Bellevergue P., Grand-Perret T., Ajakane M., Baudent V., Boissin P., Boursier E., Loriolle F., Duhamel L., Charon D., and Kirilovsky J. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem. 266 (1991) 15771-15781
17. Xie W., Samoriski G.M., McLaughlin J.P., Romoser V.A., Smrcka A., Hinkle P.M., Bidlack J.M., Gross R.A., Jiang H., and Wu D. Genetic alteration of phospholipase C beta3 expression modulates behavioral and cellular responses to mu opioids. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 10385-10390
18. Yaffe D., and Saxel O. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 270 (1977) 725-727
19. Yaksh T.L. Pharmacology and mechanisms of opioid analgesic activity. Acta Anaesthesiol. Scand. 41 (1997) 94-111
20. Ziel F.H., Venkatesan N., and Davidson M.B. Glucose transport is rate limiting for skeletal muscle glucose metabolism in normal and STZ-induced diabetic rats. Diabetes 37 (1988) 885-890